Joseph M. Burnett - 09 Jan 2026 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role
CEO and President, Director
Signature
/s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett
Issuer symbol
CLPT
Transactions as of
09 Jan 2026
Net transactions value
-$272,400
Form type
4
Filing time
13 Jan 2026, 17:00:03 UTC
Previous filing
05 Jan 2026
Next filing
27 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BURNETT JOSEPH CEO and President, Director C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH /s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett 13 Jan 2026 0001721010

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLPT Common Stock Options Exercise $50,000 +20,000 +173% $2.50 31,565 09 Jan 2026 Direct F1
transaction CLPT Common Stock Sale $322,400 -20,000 -63% $16.12 11,565 09 Jan 2026 Direct F1, F2
holding CLPT Common Stock 217,059 09 Jan 2026 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLPT Stock Options (right to buy) Options Exercise $0 -20,000 -5.7% $0.000000 330,000 09 Jan 2026 Common Stock 20,000 $2.50 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1.
F2 Represents a weighted average sales price per share. The shares were sold at prices ranging from $15.88 to $16.43. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.
F4 The shares subject to this option vest as follows: (i) one-third of the total shares on the first anniversary of the grant date; and (ii) the remaining two-thirds of the total shares ratably on a quarterly basis over the 2-year period immediately following the first anniversary of the grant date. The grant date is November 7, 2017.